Target intelligence / Profile preview

RNA, U6 small nuclear 319, pseudogene (RNU6-319P)

Target
RNU6-319P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA)-derived sequence (pseudogene of U6 snRNA)
01

Overview

RNA, U6 small nuclear 319, pseudogene (RNU6-319P) is a processed pseudogene related to U6 small nuclear RNA (snRNA), a non-coding RNA component involved in pre-mRNA splicing as part of the spliceosome complex[1][3]. As a pseudogene, RNU6-319P does not code for functional RNA or protein: it typically lacks regulatory elements and/or contains inactivating mutations, thus it does not contribute directly to splicing or other cell processes[4]. While some pseudogenes can exert regulatory functions (such as acting as competing endogenous RNAs or miRNA decoys), there is no evidence in the current literature for a functional or disease-related role for RNU6-319P specifically[2][4]. It is not considered a therapeutic target, biomarker, receptor, or any type of gene/protein target of pharmaceutical interest, but simply a non-functional genomic remnant of the U6 snRNA gene. **Note:** - RNU6-319P is neither a *therapeutic target* nor a protein/RNA with direct biological or pharmacological relevance—it is a non-functional pseudogene[4]. - There is nothing unique about its “319” variant reported in databases[4]; it is one of many such pseudogenes in the human genome. - Its presence in target lists is likely a mistake or artifact of high-throughput genomic annotation, hence is_incorrect: true.

Other names
RNU6-319PU6 small nuclear RNA 319 pseudogeneRNA, U6 small nuclear 319, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 319, pseudogene (RNU6-319P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 319, pseudogene (RNU6-319P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call